{"organizations": [], "uuid": "52ace4217f4c8347505e2ce6ea3de2aa9eeb02dc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 1, "shares": 1, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-telix-pharmaceuticals-establishes/brief-telix-pharmaceuticals-establishes-japanese-subsidiary-idUSFWN1P900R", "country": "US", "domain_rank": 408, "title": "BRIEF-‍Telix Pharmaceuticals establishes Japanese subsidiary", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-15T04:23:00.000+02:00", "replies_count": 0, "uuid": "52ace4217f4c8347505e2ce6ea3de2aa9eeb02dc"}, "author": "", "url": "https://www.reuters.com/article/brief-telix-pharmaceuticals-establishes/brief-telix-pharmaceuticals-establishes-japanese-subsidiary-idUSFWN1P900R", "ord_in_thread": 0, "title": "BRIEF-‍Telix Pharmaceuticals establishes Japanese subsidiary", "locations": [], "entities": {"persons": [{"name": "shintaro nishimura", "sentiment": "none"}], "locations": [{"name": "japan", "sentiment": "none"}], "organizations": [{"name": "telix pharmaceuticals", "sentiment": "negative"}, {"name": "telix pharmaceuticals ltd", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 14 (Reuters) - Telix Pharmaceuticals Ltd:\n* ‍TELIX PHARMACEUTICALS ESTABLISHES JAPANESE SUBSIDIARY, APPOINTS KEY EXECUTIVES​\n* ‍ANNOUNCED ESTABLISHMENT TELIX PHARMACEUTICALS (JAPAN) LTD (“TELIX JAPAN”)​\n* TELIX PHARMACEUTICALS- ‍TO LEAD TELIX JAPAN, SHINTARO NISHIMURA & TAKESHI OKA APPOINTED AS PRESIDENT & COO, AND CHIEF MEDICAL OFFICER (JAPAN), RESPECTIVELY​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-01-15T04:23:00.000+02:00", "crawled": "2018-01-15T04:40:01.040+02:00", "highlightTitle": ""}